Featured Conference
Patient Registries
Obtaining real world effectiveness data about products in various patient populations critical for your company’s success.
February 1 – 3, 2006 * Atlanta, GA
Key Speakers
- Dennis Decktor, Medical Affairs Senior Director, CENTOCOR.
- Aida Cicic M.D., Director, Post Marketing Clinical Studies, MEDTRONIC, INC..
- Elizabeth Mutisya (Invited), Vice President Medical Affairs, CEPHALON.
- Steve E. Phurrough, M.D., MPA, Director, Coverage and Analysis Group, OFFICE OF CLINICAL STANDARDS AND QUALITY, CMS.
- Peggy Schrammel, Executive Director, Late Phase Development Division, PHARMANET.
Key Topics
- Web based enrollment strategies, data collection and verification funtionalities
- Management of relationships and data access controls between patients and providers
- Online reporting functions to chart patient response to therapy
- Aggregate reporting functionalities for sponsors of clinical trials
- FDA regulations and guidance impacting patient registries
Event Summary
Patient registries provide a unique opportunity within the life science industry to acquire real-world data on product performance, quality of life and segmentation. As pharmaceutical companies are conducting Phase IV or post-marketing trials, they often initiate patient registries as a method of collection and aggregation of the massive amount of data collected from participants. One of the key focuses of this program will be assuring that both commercial and medical goals are met through the utilization of the registry. Through utilizing the registry as both a marketing tool as well as examining the scientific results associated with participating in the trial, sponsors will meet the goal of a comprehensive registry. Another issue that will be addressed through this program is creating functional registries that clinicians and patients will utilize to chart their progress and indications. Without ensuring this functionality, there is very little opportunity for a successful trial. Finally, the program will address regulatory concerns related to utilizing a patient registry, in light of both HIPPA regulations as well as evolving FDA regulations impacting the industry. Through participation in this program, delegates will walk away with the knowledge and expertise required to successfully implement a patient registry.
Advisory Board
- Stephen Webb, EVP, Registrat
- Rich Gliklich, CEO, Outcome
- Chris Pashos, PhD, VP amd Executive Director HERQULES, Abt Associates
- Sean Zhao, Associate Medical Director, Amgen
- June Lee, Medical Director, Genentech,Inc.
- Michael Karukin, PA, PhD, Associate Director, Medical Affairs, IVAX Pharmaceuticals
Event Speakers
- Winifred Werther, Epidemiologist, GENENTECH INC..
- Zaffer A. Syed , Manager, Scientific Studies Department, ST JUDE MEDICAL.
- Stephen Webb, Executive Vice President, REGISTRAT.
- Campbell P. Howard, Clinical Director in Clinical Research & Medical Affairs, NOVO NORDISK INC..
- Dennis Decktor, Medical Affairs Senior Director, CENTOCOR.
- Aida Cicic M.D., Director, Post Marketing Clinical Studies, MEDTRONIC, INC..
- Elizabeth Mutisya (Invited), Vice President Medical Affairs, CEPHALON.
- Steve E. Phurrough, M.D., MPA, Director, Coverage and Analysis Group, OFFICE OF CLINICAL STANDARDS AND QUALITY, CMS.
- Peter Holthe, Director, Clinical Data Management and Systems, HOFFMAN LA ROCHE.
- Nancy Dreyer, Chief of Scientific Affairs, OUTCOME.
- Chris Pashos, PhD, Vice President and Executive Director Health Economics and Research, ABT ASSOCIATES.
- Peggy Schrammel, Executive Director, Late Phase Development Division, PHARMANET.
- Gene Poggio, PhD, Managing Vice President and Executive Director, Statistics and Epidemiology, ABT ASSOCIATES.
- Steve Fosburg, MA, Senior Vice President, Clinical Research Studies, ABT ASSOCIATES.
- Inder Kaul, MD, MPH, Managing Vice President, ABT ASSOCIATES.
- Richard Gliklich, MD, CEO, OUTCOME.
- Robert Kwong, Associate General Counsel, OUTCOME.
- Robin Pepper, Director of Professional Services, OUTCOME.
Visit the conference website for more information and to register.
For more information, please contact:
Keisha Babb
CGI Tower, 3rd Floor
Warrens
St. Michael, Barbados
Tel :1.246.417.5413
Fax :1.888.844.4901
EMail : pharma@marcusevansbb.com
